Fred Hutchinson Cancer Center is a clinical research site located in Seattle, Washington, United States 98109.
Crixeo Health Trust Score: 89/100 (GOOD). This profile has not yet been claimed by the site owner.
Fred Hutchinson Cancer Center has participated in 297 clinical trials with 240 currently active.
Therapeutic areas: Metastatic Non-small Cell Lung Cancer With MTAP Deletion, Solid Tumor, Adult, Colorectal Cancer.
Sponsors: Bristol-Myers Squibb, A2 Biotherapeutics Inc., National Cancer Institute (NCI).
Trust Score: 89/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.
Fred Hutchinson Cancer Center has a Crixeo Trust Score of 89/100 (GOOD). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.
Fred Hutchinson Cancer Center has 297 clinical trials on record, with 240 currently active. Their work covers Metastatic Non-small Cell Lung Cancer With MTAP Deletion, Solid Tumor, Adult, Colorectal Cancer.
Fred Hutchinson Cancer Center has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.
Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.